The study tested AlphaFold3, Boltz-2 and Chai-1 on 551 molecules bound to the SARS-CoV-2 NSP3 macrodomain, known as Mac1. Of these, 489 complexes were considered suitable for evaluation. Each system reproduced more than half of the experimentally measured binding poses to within 2 angstroms, a measure of structural distance.

The researchers also examined whether the predictions could indicate how strongly molecules bind and help filter likely drug candidates from false positives. Boltz-2 showed the strongest relationship with measured binding strength, while traditional docking and some AI confidence scores provided partly independent information. In three additional screens, combining these signals appeared more useful for ranking candidates than relying on one score alone, but the AI pose-confidence measure did not outperform docking or Boltz-2 affinity predictions at separating binders from non-binders.